{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:20:29Z","timestamp":1790997629142,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,29]],"date-time":"2010-05-29T00:00:00Z","timestamp":1275091200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10689-010-9348-3","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T04:48:59Z","timestamp":1275022139000},"page":"495-502","source":"Crossref","is-referenced-by-count":43,"title":["Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study"],"prefix":"10.1007","volume":"9","author":[{"given":"Noralane M.","family":"Lindor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiley J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Shane Pankratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Domchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cathie Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus","family":"Couch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,29]]},"reference":[{"issue":"1","key":"9348_CR1","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/bcr1365","volume":"8","author":"AC Antoniou","year":"2005","unstructured":"Antoniou AC, Durocher F, Smith P et al (2005) BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8(1):R3","journal-title":"Breast Cancer Res"},{"key":"9348_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-8-155","volume":"8","author":"DG Evans","year":"2008","unstructured":"Evans DG, Shenton A, Woodward E et al (2008) Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer 8:155","journal-title":"BMC Cancer"},{"issue":"9","key":"9348_CR3","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-07-4436","volume":"14","author":"RL Milne","year":"2008","unstructured":"Milne RL, Osorio A, Cajal TR et al (2008) The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 14(9):2861\u20132869","journal-title":"Clin Cancer Res"},{"issue":"11","key":"9348_CR4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.ejhg.5201256","volume":"12","author":"F Marroni","year":"2004","unstructured":"Marroni F, Aretini P, D\u2019Andrea E et al (2004) Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1\/2 mutations. Eur J Hum Genet 12(11):899\u2013906","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"9348_CR5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329\u20131333","journal-title":"J Clin Oncol"},{"issue":"1","key":"9348_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bjc.6603535","volume":"96","author":"E Levy-Lahad","year":"2007","unstructured":"Levy-Lahad E, Friedman E (2007) Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 96(1):11\u201315","journal-title":"Br J Cancer"},{"issue":"8","key":"9348_CR7","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.2005.10.035","volume":"23","author":"SA Narod","year":"2005","unstructured":"Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23(8):1656\u20131663","journal-title":"J Clin Oncol"},{"issue":"1","key":"9348_CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00016340500324621","volume":"85","author":"M Sogaard","year":"2006","unstructured":"Sogaard M, Kjaer SK, Gayther S (2006) Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand 85(1):93\u2013105","journal-title":"Acta Obstet Gynecol Scand"},{"key":"9348_CR9","unstructured":"National Comprehensive Cancer Network (2008) NCCN clinical practice guidelines in oncology. Colorectal cancer screening. Available via www.nccn.org . Cited 15 Dec 2009"},{"key":"9348_CR10","first-page":"1","volume":"38","author":"NM Lindor","year":"2008","unstructured":"Lindor NM, McMaster ML, Lindor CJ et al (2008) Concise handbook of familial cancer susceptibility syndromes\u2014second edition. J Natl Cancer Inst Monogr 38:1\u201393","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"4","key":"9348_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10689-007-9150-z","volume":"6","author":"NM Lindor","year":"2007","unstructured":"Lindor NM, Lindor RA, Apicella C et al (2007) Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models. Fam Cancer 6(4):473\u2013482","journal-title":"Fam Cancer"},{"key":"9348_CR12","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"1989","unstructured":"Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York"},{"key":"9348_CR13","unstructured":"Research Development Core Team (2005) R: a language and environment for statistical computing. Available via http:\/\/www.R-project.org . Cited 27 Sept 2006"},{"issue":"7","key":"9348_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","volume":"45","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Hardy R, Walker L et al (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 45(7):425\u2013431","journal-title":"J Med Genet"},{"issue":"11","key":"9348_CR15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1056\/NEJMoa0907727","volume":"362","author":"S Wacholder","year":"2010","unstructured":"Wacholder S, Hartge P, Prentice R et al (2010) Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362(11):986\u2013993","journal-title":"N Engl J Med"},{"issue":"6","key":"9348_CR16","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/bcr644","volume":"5","author":"C Apicella","year":"2003","unstructured":"Apicella C, Andrews L, Hodgson SV et al (2003) Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Res 5(6):R206\u2013R216","journal-title":"Breast Cancer Res"},{"issue":"6","key":"9348_CR17","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480\u20131490","journal-title":"J Clin Oncol"},{"issue":"1","key":"9348_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62(1):145\u2013158","journal-title":"Am J Hum Genet"},{"issue":"11","key":"9348_CR19","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen ESJ, Gudbjartsson DF et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701\u20132712","journal-title":"J Clin Oncol"},{"issue":"20","key":"9348_CR20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","volume":"336","author":"FJ Couch","year":"1997","unstructured":"Couch FJ, DeShano ML, Blackwood MA et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336(20):1409\u20131415","journal-title":"N Engl J Med"},{"key":"9348_CR21","volume-title":"Surveillance, epidemiology, and end results SEER program stat database: incidence\u2013SEER 9 regs public-use. Version 5","author":"National Cancer Institute","year":"2003","unstructured":"National Cancer Institute (2003) Surveillance, epidemiology, and end results SEER program stat database: incidence\u2013SEER 9 regs public-use. Version 5, 2nd edn. National Cancer Institute, Bethesda, MD","edition":"2"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9348-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-010-9348-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9348-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:46:03Z","timestamp":1559238363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-010-9348-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,29]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9348"],"URL":"https:\/\/doi.org\/10.1007\/s10689-010-9348-3","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,29]]}}}